Read More Pharma Industry News ABM Therapeutics begins phase 1 trial of BRAF inhibitor ABM-1310 ABM Therapeutics said that the first cancer patient has been enrolled and dosed with its lead candidate ABM-1310,… bypharmanewsdailyJune 23, 2020
